Pharma Lawyer Is New Deputy Director At USPTO17/02/2011 by William New, Intellectual Property Watch 2 Comments Print This Post A Washington intellectual property lawyer and private sector representative has been named deputy director at the United States Patent and Trademark Office. Her area of expertise is pharmaceutical, biotechnology and other life science issues, USPTO said in a release. Teresa Stanek Rea “is a leading attorney in the field of intellectual property with more than 25 years of legal experience and a past president of the American Intellectual Property Law Association (AIPLA),” the release said. “She is currently a partner in Crowell & Moring LLP’s Washington, D.C., office where she has focused on intellectual property and dispute resolution related to pharmaceutical, biotechnology and other life science issues. Rea has experience in drafting infringement and validity opinions, as well as experience in interference and licensing matters.”The release said: “Serving alongside Under Secretary of Commerce for Intellectual Property and Director of the USPTO David Kappos, Rea will take charge of an office that encourages innovation and technological advancement, and helps businesses protect their investments, promote their goods and safeguard against deception in the marketplace.”“Rea is a member of several technical and legal associations and has been a frequent lecturer and publisher on patent topics including biotechnology, nanotechnology, licensing, technology transfer, patent practice, export control and interferences. She received a Juris Doctor degree from Wayne State University and a Bachelor of Science degree in pharmacy from the University of Michigan.”Related Articles:USPTO Deputy Director To Leave Next Month USPTO Deputy Director’s Qualifications Backed; Lawsuit Could Return Doll Is New Deputy At USPTO; More Changes On The Way William New may be reached at firstname.lastname@example.org."Pharma Lawyer Is New Deputy Director At USPTO" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.